Skip to content

LICI.NS · bank / insurer · relative-multiples view

Life Insurance Corporation of India (LICI.NS): Valuation Snapshot

Life Insurance Corporation of India (LICI.NS) is a bank, insurer or other financial, and a discounted-cash-flow model is the wrong lens for one, so TickerWorth does not publish a DCF fair value for it. What its filings and market data do show is below. Snapshot as of Oct 19, 2026.

Model by · generated from public market data · Updated Oct 19, 2026 · How these pages are made

How is a bank like LICI.NS valued?

We don’t publish a DCF for this company

This is a bank / insurer / financial. A free-cash-flow DCF is structurally the wrong lens here (their debt and float are raw material, not financing), so we don't publish one. Our bank model (justified price-to-book) declined to value it too: our cost-of-equity inputs are US-market (10-year Treasury, US equity risk premium); we don't apply them to a INR listing. The price-to-book and price-to-earnings figures below are context for comparison, not a fair value.

Bank model (justified price-to-book)

Not published. Our cost-of-equity inputs are US-market (10-year Treasury, US equity risk premium); we don't apply them to a INR listing.

What is LICI.NS's TickerWorth Score?

B58/100

Cheap against our estimate — but a weaker business

Compared with Financial Services companies in India

Its strongest point: trades below our estimate of what it's worth. Its weakest: profitability is weak.

  • Value · 79 of 100

    Cheaper than 79% of Financial Services companies in India

  • Price vs worth · 100 of 100
  • Quality · 10 of 100

    More profitable than 10% of Financial Services companies in India

  • Financial health · 86 of 100

    Financially stronger than 86% of Financial Services companies in India

  • Growth · 37 of 100

    Growing faster than 37% of Financial Services companies in India

  • Momentum · 30 of 100

    Outperformed 30% of Financial Services companies in India over the past year

Confidence: Medium confidence · Scored

Get the Undervalued Company of the Week.

The Weekly Undervalued

The Undervalued Company of the Week, with its fair-value range and the growth its price implies. We'll email you when the weekly list starts. Not advice or trading calls.

Price
₹393.35
Market cap
₹2,487,937,925,120
52-week high
₹468.48
52-week low
₹360.75
Currency
INR
Exchange
NSE

Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.

What we can say

Life Insurance Corporation of India (LICI.NS) is a bank, insurer or other financial, and a free-cash-flow discounted-cash-flow (DCF) model is structurally the wrong lens for it: for these businesses debt and float are raw material, not financing, so there is no meaningful 'free cash flow' to discount. Instead of a misleading intrinsic-value number, this page reads LICI.NS the way financials are actually valued — on relative multiples such as price-to-earnings and, above all, price-to-book — plus a plain description of where the stock trades. It is a descriptive snapshot, not a valuation, and not investment advice.

Read the full reasoning

On the numbers we do have, LICI.NS trades at a recent price of ₹393.35, a market capitalisation of about ₹2,487,937,925,120, sitting 30% of the way up its 52-week range (₹360.75–₹468.48), on the NSE.

The standard alternative to a DCF is relative valuation — comparing LICI.NS's trading multiples against a sector benchmark. Here that gives P/E of 8.3× (cheaper than the peer median of 14.2×); Fwd P/E of 6.7× (cheaper than the peer median of 13.3×); P/B of 2.8× (in line with the peer median of 2.6×); P/S of 0.2× (cheaper than the peer median of 4.7×); Dividend yield of 2.5% (cheaper than the peer median of 1.9%). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.

The asset, or book-value, lens is the classic tool for asset-heavy businesses and financials. LICI.NS shows a price-to-book (P/B) of 2.82 and book value of ₹139.61 per share. Price-to-book compares the market price to the accounting net-asset value per share; below 1.0 can mean a discount to net assets or that the market is pricing in trouble — descriptive either way, never a buy signal on its own.

Finally, a price-based read — explicitly not a valuation. LICI.NS is in a down-trend (price below both its 50- and 200-day averages), trading -16.0% from its 52-week high. Over the past year the stock is -10.8%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.

To be exact about what this page is not: we are not saying the numbers for LICI.NS are unavailable. They are, and they are above. We are saying a discounted-cash-flow model is the wrong instrument for this kind of business, and publishing one anyway — because the inputs happen to exist — would be a precise answer to the wrong question. Refusing is the more useful answer, and it is the same rule we apply to every name in this category.

LICI.NS vs peers

Sector benchmark (bellwethers, not direct competitors).

MultipleLICI.NSPeer medianRead
P/E8.3×14.2×cheaper than
Fwd P/E6.7×13.3×cheaper than
P/B2.8×2.6×in line with
P/S0.2×4.7×cheaper than
Dividend yield2.5%1.9%cheaper than

What does Life Insurance Corporation of India do?

What does it do?

Life Insurance Corporation of India provides life insurance products in India, Fiji, Mauritius, and the United Kingdom. The company offers insurance plans, including endowment, whole life, term insurance, money back, and term assurance plans, as well as riders comprising accidental death and disability benefit, critical illness benefit, and premium waiver benefit riders. It operates in the Insurance - Life industry (Financial Services sector), headquartered in India. The company employs roughly 84,565 people.

How does it make money?

The business turns 10.0T in annual revenue into profit. Out of every $100 of sales, about $6 is left as operating profit (operating margin of 6.4%), after a 11% gross margin on the products/services it sells. After all costs, taxes and interest, 6.5% of revenue becomes bottom-line net profit.

Is it financially healthy?

Financially it looks solid: carries modest debt (0.4× equity), and is currently profitable.

LICI.NS insider trading

Insider filings are available for US-listed companies only.

Not investment advice. TickerWorth Score is a model output.

A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.